Nonspecific distribution and uncontrollable release of drugs in conventional drug delivery
systems (CDDSs) have led to the development of smart nanocarrier-based drug delivery …

Hydrogels prepared via self-assembly offer scalable and tunable platforms for drug delivery
applications. Molecular-scale self-assembly leverages an interplay of attractive and …

Rapidly developing polymeric micelles as potential targeting carriers has intensified the
need for better understanding of the underlying principles related to the selection of suitable …

Peptides and peptide-conjugates, comprising natural and synthetic building blocks, are an
increasingly popular class of biomaterials. Self-assembled nanostructures based on …

In atherosclerosis, resident vascular smooth muscle cells (VSMCs) in the blood vessels
become highly plastic and undergo phenotypic switching from the quiescent, contractile …

Because free therapeutic drug molecules often have adverse effects on normal tissues,
deliver scanty drug concentrations and exhibit a potentially low efficacy at pathological sites …

Nanoparticle drug delivery has many advantages over small molecule therapeutics,
including reducing off-target side effects and increasing drug potency. However, many …

Proteins and their interactions in and out of cells must be well-orchestrated for the healthy
functioning and regulation of the body. Even the slightest disharmony can cause diseases …

Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …

Chronic kidney disease (CKD) affects 15% of the US adult population. However, most
clinically available drugs for CKD show low bioavailability to the kidneys and non‐specific …